PlainPharmaWatch

CMS Open Payments · Tool

McKesson Drug Company LLC vs Atlas Spine, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

McKesson Drug Company LLC has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 4,613, versus 2,488 for the other company. Its single largest recorded recipient represents 65.2% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

McKesson Drug Company LLC
HHI 4,613 · top recipient 65.2%
Ranked #397 of 1,838 companies by HHI
Atlas Spine, Inc.
HHI 2,488 · top recipient 25.9%
Ranked #652 of 1,838 companies by HHI

Payment Overview

Total Payments
$30.7K
% of Industry
0.0%
Transactions
18
Avg per Transaction
$1.7K
Recipients
18
Avg per Recipient
$1.7K
Payment Types
3
Top Payment Type
Charitable Contribution
Company B

Atlas Spine, Inc.

Total Payments
$31.3K
% of Industry
0.0%
Transactions
17
Avg per Transaction
$1.8K
Recipients
17
Avg per Recipient
$1.8K
Payment Types
2
Top Payment Type
Royalty or License

Highlighted values indicate the higher figure for each metric.

Total payments compared

McKesson Drug Company LLC vs Atlas Spine, Inc. - total reported payments in CMS Open Payments PY2024

Atlas Spine, Inc.$31.3KMcKesson Drug Company LLC$30.7K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

McKesson Drug Company LLC

Charitable Contribution $29.0K

94.6%

Food and Beverage $1.3K

4.1%

Honoraria $407.00

1.3%

Atlas Spine, Inc.

Royalty or License $31.1K

99.5%

Food and Beverage $163.38

0.5%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

McKesson Drug Company LLC

  1. 1

    Ochsner Clinic Foundation

    $20,000.00 · 1 txns

  2. 2

    Yale-New Haven Hospital

    $5,000.00 · 1 txns

  3. 3

    Kaleida Health

    $2,500.00 · 1 txns

  4. 4

    Uams Medical Center

    $1,500.00 · 1 txns

  5. 5

    JOSEPH EZRA GLASER

    $407.00 · 1 txns

Atlas Spine, Inc.

  1. 1

    STEVEN C LUDWIG

    $8,110.29 · 4 txns

  2. 2

    Alex R Vaccaro

    $8,110.29 · 4 txns

  3. 3

    Andrew C Hecht

    $8,110.29 · 4 txns

  4. 4

    Brian O'Shaughnessy

    $6,761.61 · 4 txns

  5. 5

    Karthik Madhavan

    $163.38 · 1 txns

Summary Comparison

Metric McKesson Drug Company LLC Atlas Spine, Inc.
Total Payments $30.7K $31.3K
% of Industry Total 0.0% 0.0%
Transaction Count 18 17
Avg per Transaction $1.7K $1.8K
Recipient Count 18 17
Avg per Recipient $1.7K $1.8K
Payment Type Count 3 2
Top Payment Type Charitable Contribution Royalty or License

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.